Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Thoracic Surgery

Free Subscription Articles published in Catheter Cardiovasc Interv Retrieve available abstracts of 136 articles: HTML format Text format

Single Articles

September 2018
1. DADU RT, Xu J, Rehman H, von Ballmoos MW, et al
   Optimal positioning of self-expanding valves before deployment decreases paravalvular regurgitation following transcatheter aortic valve replacement.
   Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27829.
   PubMed     Text format     Abstract available
   
   
   
2. SHAUKAT A, Mooney M, Burke MN, Brilakis ES, et al
   Use of chronic total occlusion percutaneous coronary intervention techniques for treating acute vessel closure.
   Catheter Cardiovasc Interv. 2018 Sep 14. doi: 10.1002/ccd.27868.
   PubMed     Text format     Abstract available
   
   
   
3. OKUMURA H, Hayashi H, Harada M, Mikuri M, et al
   Retrograde percutaneous coronary intervention for acute myocardial infarction following blunt chest trauma.
   Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27836.
   PubMed     Text format     Abstract available
   
   
   
4. BOI A, Sanna F, Rossi A, Loi B, et al
   Acute myocardial infarction secondary to blunt chest trauma in motorcycle accident: A rare combination where percutaneous coronary intervention and intravascular imaging optimization are needed.
   Catheter Cardiovasc Interv. 2018 Sep 12. doi: 10.1002/ccd.27725.
   PubMed     Text format     Abstract available
   
   
   
5. BUTERA G, Mansour NB, De Marco F
   Emergency trans-catheter coronary intervention for left main compression secondary to pulmonary hypertension in a 4-year-old child.
   Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27796.
   PubMed     Text format     Abstract available
   
   
   
6. RAFIQ A, Chutani S, Krim NR
   Coronary intervention and arteria lusoria-Not simple as it may seem.
   Catheter Cardiovasc Interv. 2018 Sep 9. doi: 10.1002/ccd.27803.
   PubMed     Text format     Abstract available
   
   
   August 2018
7. GURM HS, Seth M, Dixon SR, Michael Grossman P, et al
   Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions.
   Catheter Cardiovasc Interv. 2018 Aug 25. doi: 10.1002/ccd.27819.
   PubMed     Text format     Abstract available
   
   
   
8. KHAN JM, Lederman RJ
   Adventures across the second dimension: Predicting left ventricular outflow tract obstruction following transcatheter mitral valve replacement.
   Catheter Cardiovasc Interv. 2018;92:388-389.
   PubMed     Text format    
   
   
   
9. CHATTERJEE A, Hillegass WB
   Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.
   Catheter Cardiovasc Interv. 2018;92:431-432.
   PubMed     Text format    
   
   
   July 2018
10. TAM DY, Vo TX, Wijeysundera HC, Dvir D, et al
    Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2018 Jul 19. doi: 10.1002/ccd.27686.
    PubMed     Text format     Abstract available
    
    
    
11. CHEN GC, Lu XM, Song YM, Gyawail L, et al
    A 3-year experience of a simple, novel technique for accurate ostial/non-ostial coronary stenting: The buddy balloon anchor stent technique.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27667.
    PubMed     Text format     Abstract available
    
    
    
12. ROGERS T, Gai J, Torguson R, Okubagzi PG, et al
    Predicted magnitude of alternate access in the contemporary transcatheter aortic valve replacement era.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27668.
    PubMed     Text format     Abstract available
    
    
    
13. SMILOWITZ NR, Mohananey D, Razzouk L, Weisz G, et al
    Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27673.
    PubMed     Text format     Abstract available
    
    
    
14. NOAMAN S, Goh CY, Vogrin S, Brennan AL, et al
    Comparison of short-term clinical outcomes of proximal versus nonproximal lesion location in patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction: The PROXIMITI study.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27665.
    PubMed     Text format     Abstract available
    
    
    
15. WUSTROW I, Sarafoff N, Haller B, Rossner L, et al
    Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27678.
    PubMed     Text format     Abstract available
    
    
    
16. RILEY RF, McCabe JM, Kalra S, Lazkani M, et al
    Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Catheter Cardiovasc Interv. 2018 Jul 18. doi: 10.1002/ccd.27679.
    PubMed     Text format     Abstract available
    
    
    
17. DAMLUJI AA, Murman M, Byun S, Moscucci M, et al
    Alternative access for transcatheter aortic valve replacement in older adults: A collaborative study from France and United States.
    Catheter Cardiovasc Interv. 2018 Jul 3. doi: 10.1002/ccd.27690.
    PubMed     Text format     Abstract available
    
    
    May 2018
18. AKODAD M, Huet F, Dupuy AM, Lotierzo M, et al
    Letter to the editor concerning "comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventi
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27618.
    PubMed     Text format    
    
    
    
19. JACKSON M, Austin D, Kwok CS, Rashid M, et al
    The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27642.
    PubMed     Text format     Abstract available
    
    
    
20. TAMEZ H, Genereux P, Yeh RW, Amin AP, et al
    Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study.
    Catheter Cardiovasc Interv. 2018 May 4. doi: 10.1002/ccd.27638.
    PubMed     Text format     Abstract available
    
    
    April 2018
21. SETO AH, Shroff A, Abu-Fadel M, Blankenship JC, et al
    Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions.
    Catheter Cardiovasc Interv. 2018 Apr 24. doi: 10.1002/ccd.27637.
    PubMed     Text format     Abstract available
    
    
    
22. VILLABLANCA PA, Mohananey D, Ramakrishna H
    Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2018 Apr 16. doi: 10.1002/ccd.27639.
    PubMed     Text format    
    
    
    March 2018
23. NDREPEPA G, Kastrati A
    Rebuttal: Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27617.
    PubMed     Text format    
    
    
    
24. KINDYA B, Ouzan E, Lerakis S, Gonen E, et al
    Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27607.
    PubMed     Text format     Abstract available
    
    
    
25. HONDA Y, Yamawaki M, Araki M, Tada N, et al
    Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes.
    Catheter Cardiovasc Interv. 2018 Mar 30. doi: 10.1002/ccd.27596.
    PubMed     Text format     Abstract available
    
    
    
26. DE PALMA R, Settergren M, Ruck A, Linder R, et al
    Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Mar 25. doi: 10.1002/ccd.27595.
    PubMed     Text format     Abstract available
    
    
    
27. MOHDNAZRI SR, Karamasis GV, Al-Janabi F, Cook CM, et al
    The impact of coronary chronic total occlusion percutaneous coronary intervention upon donor vessel fractional flow reserve and instantaneous wave-free ratio: Implications for physiology-guided PCI in patients with CTO.
    Catheter Cardiovasc Interv. 2018 Mar 22. doi: 10.1002/ccd.27587.
    PubMed     Text format     Abstract available
    
    
    
28. EITAN A, Witt J, Stripling J, Haselbach T, et al
    Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli >/=26 mm.
    Catheter Cardiovasc Interv. 2018 Mar 9. doi: 10.1002/ccd.27588.
    PubMed     Text format     Abstract available
    
    
    
29. NIIDA T, Murai T, Yonetsu T, Kanaji Y, et al
    Coronary physiological assessment combining fractional flow reserve and index of microcirculatory resistance in patients undergoing elective percutaneous coronary intervention with grey zone fractional flow reserve.
    Catheter Cardiovasc Interv. 2018 Mar 8. doi: 10.1002/ccd.27570.
    PubMed     Text format     Abstract available
    
    
    
30. ANANTHAKRISHNA R, Kristanto W, Liu L, Chan SP, et al
    Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all-comers registry.
    Catheter Cardiovasc Interv. 2018 Mar 7. doi: 10.1002/ccd.27577.
    PubMed     Text format     Abstract available
    
    
    
31. XIE R, Hillegass WB
    Long-term survival prospects of patients undergoing percutaneous coronary intervention: Envisioning the future.
    Catheter Cardiovasc Interv. 2018;91:696.
    PubMed     Text format     Abstract available
    
    
    February 2018
32. DAUTOV R, Ybarra LF, Nguyen CM, Gibrat C, et al
    Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Feb 26. doi: 10.1002/ccd.27545.
    PubMed     Text format     Abstract available
    
    
    
33. AZARRAFIY R, Albuquerque FN, Carrillo RG, Cohen MG, et al
    Coil embolization to successfully treat annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27546.
    PubMed     Text format     Abstract available
    
    
    
34. HIOKI H, Watanabe Y, Kozuma K, Yamamoto M, et al
    Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2018 Feb 22. doi: 10.1002/ccd.27547.
    PubMed     Text format     Abstract available
    
    
    
35. MURAI T, Yonetsu T, Kanaji Y, Usui E, et al
    Prognostic value of the index of microcirculatory resistance after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.
    Catheter Cardiovasc Interv. 2018 Feb 15. doi: 10.1002/ccd.27529.
    PubMed     Text format     Abstract available
    
    
    
36. ZIVELONGHI C, van Kuijk JP, Nijenhuis V, Poletti E, et al
    First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusions with the hybrid algorithm.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27539.
    PubMed     Text format     Abstract available
    
    
    
37. MCNEICE AH, Brooks M, Hanratty CG, Stevenson M, et al
    A retrospective study of radiation dose measurements comparing different cath lab X-ray systems in a sample population of patients undergoing percutaneous coronary intervention for chronic total occlusions.
    Catheter Cardiovasc Interv. 2018 Feb 7. doi: 10.1002/ccd.27541.
    PubMed     Text format     Abstract available
    
    
    
38. SAWANT AC, Bhardwaj A, Banerjee K, Jobanputra Y, et al
    Fractional flow reserve guided percutaneous coronary intervention results in reduced ischemic myocardium and improved outcomes.
    Catheter Cardiovasc Interv. 2018 Feb 6. doi: 10.1002/ccd.27525.
    PubMed     Text format     Abstract available
    
    
    
39. TAKAGI H, Mitta S, Ando T
    Long-term survival after transcatheter versus surgical aortic valve replacement for aortic stenosis: A meta-analysis of observational comparative studies with a propensity-score analysis.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27521.
    PubMed     Text format     Abstract available
    
    
    
40. WITBERG G, Lador A, Yahav D, Kornowski R, et al
    Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies.
    Catheter Cardiovasc Interv. 2018 Feb 1. doi: 10.1002/ccd.27518.
    PubMed     Text format     Abstract available
    
    
    
41. HEUSER RR
    Perforations and how to manage: The coronary interventionalist and peripheral interventionalist working together for a solution.
    Catheter Cardiovasc Interv. 2018;91:308-309.
    PubMed     Text format     Abstract available
    
    
    
42. PLITT A, Dangas G
    Cardiac enzyme elevation after coronary revascularization.
    Catheter Cardiovasc Interv. 2018;91:224-225.
    PubMed     Text format     Abstract available
    
    
    
43. MISUMIDA N, Moliterno DJ
    Hybrid coronary revascularization: Time for a new comparator?
    Catheter Cardiovasc Interv. 2018;91:213-214.
    PubMed     Text format     Abstract available
    
    
    January 2018
44. LIU S, Song C, Zhao Y, Zhu C, et al
    The impact of acquired thrombocytopenia on long-term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients.
    Catheter Cardiovasc Interv. 2018 Jan 25. doi: 10.1002/ccd.27498.
    PubMed     Text format     Abstract available
    
    
    
45. BADRI M, Shapiro T, Wang Y, Minges KE, et al
    Adoption of the transradial approach for percutaneous coronary intervention and rates of vascular complications following transfemoral procedures: Insights from NCDR.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27490.
    PubMed     Text format     Abstract available
    
    
    
46. EL SABBAGH A, Eleid MF, Matsumoto JM, Anavekar NS, et al
    Three-dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification.
    Catheter Cardiovasc Interv. 2018 Jan 23. doi: 10.1002/ccd.27488.
    PubMed     Text format     Abstract available
    
    
    
47. DONG H, Che W, Jiang X, Peng M, et al
    Carotid artery stenting followed by open heart surgery in 323 patients: One-year results and influencing factors.
    Catheter Cardiovasc Interv. 2018 Jan 22. doi: 10.1002/ccd.27486.
    PubMed     Text format     Abstract available
    
    
    
48. KAGASE A, Yamamoto M, Shimura T, Kodama A, et al
    Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.
    Catheter Cardiovasc Interv. 2018 Jan 11. doi: 10.1002/ccd.27483.
    PubMed     Text format     Abstract available
    
    
    
49. GARCIA S, Kelly R, Mbai M, Gurevich S, et al
    Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Catheter Cardiovasc Interv. 2018 Jan 9. doi: 10.1002/ccd.27478.
    PubMed     Text format     Abstract available
    
    
    
50. ALASTI M, Rashid H, Rangasamy K, Kotschet E, et al
    Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27463.
    PubMed     Text format     Abstract available
    
    
    
51. MALIK SA, Brilakis ES, Pompili V, Chatzizisis YS, et al
    Lost and found: Coronary stent retrieval and review of literature.
    Catheter Cardiovasc Interv. 2018 Jan 4. doi: 10.1002/ccd.27464.
    PubMed     Text format     Abstract available
    
    
    
52. IVERSON A, Stanberry L, Garberich R, Antos A, et al
    Impact of sleep deprivation on the outcomes of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2018 Jan 3. doi: 10.1002/ccd.27471.
    PubMed     Text format    
    
    
    December 2017
53. GOLDSWEIG AM, Kennedy KF, Kolte D, Abbott JD, et al
    Predictors of patient radiation exposure during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Dec 27. doi: 10.1002/ccd.27452.
    PubMed     Text format     Abstract available
    
    
    
54. KIM JH, Kim BK, Kim S, Ahn CM, et al
    Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2017 Dec 20. doi: 10.1002/ccd.27420.
    PubMed     Text format     Abstract available
    
    
    
55. WANG DD, Eng MH, Greenbaum AB, Myers E, et al
    Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
    Catheter Cardiovasc Interv. 2017 Dec 11. doi: 10.1002/ccd.27447.
    PubMed     Text format     Abstract available
    
    
    
56. MILLAN-ITURBE O, Sawaya FJ, Lonborg J, Chow DHF, et al
    Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real-world results from the East Denmark Heart Registry.
    Catheter Cardiovasc Interv. 2017 Dec 7. doi: 10.1002/ccd.27440.
    PubMed     Text format     Abstract available
    
    
    
57. RASHID HN, McCormick LM, Talman AH, Ihdayhid AR, et al
    Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Catheter Cardiovasc Interv. 2017 Dec 6. doi: 10.1002/ccd.27378.
    PubMed     Text format     Abstract available
    
    
    November 2017
58. DANIELS DV, Banerjee S, Alaswad K, Doing AH, et al
    Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry.
    Catheter Cardiovasc Interv. 2017 Nov 29. doi: 10.1002/ccd.26501.
    PubMed     Text format     Abstract available
    
    
    
59. ALKHALIL A, Golbari S, Song D, Lamba H, et al
    In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
    Catheter Cardiovasc Interv. 2017 Nov 24. doi: 10.1002/ccd.27433.
    PubMed     Text format     Abstract available
    
    
    
60. THEUERLE J, Yudi MB, Farouque O, Andrianopoulos N, et al
    Utility of the ACC/AHA lesion classification as a predictor of procedural, 30-day and 12-month outcomes in the contemporary percutaneous coronary intervention era.
    Catheter Cardiovasc Interv. 2017 Nov 15. doi: 10.1002/ccd.27411.
    PubMed     Text format     Abstract available
    
    
    
61. MURATA N, Takayama T, Hiro T, Hirayama A, et al
    Balloon pin-hole rupture during percutaneous coronary intervention for recurrent, calcified in-stent restenosis: A case report.
    Catheter Cardiovasc Interv. 2017 Nov 13. doi: 10.1002/ccd.27405.
    PubMed     Text format     Abstract available
    
    
    
62. STAHLI BE, Gebhard C, Gick M, Ferenc M, et al
    Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion.
    Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27412.
    PubMed     Text format     Abstract available
    
    
    
63. FANARI Z, Mahmaljy H, Nandish S, Goswami NJ, et al
    Simultaneous transcatheter transfemoral aortic and transeptal mitral valve replacement using Edward SAPIEN S3.
    Catheter Cardiovasc Interv. 2017 Nov 6. doi: 10.1002/ccd.27410.
    PubMed     Text format     Abstract available
    
    
    October 2017
64. BARAN DA, Visveswaran GK, Seliem A, DiVita M, et al
    Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27387.
    PubMed     Text format     Abstract available
    
    
    
65. GOYAL A, Tabak SW, Henry TD, Kobashigawa JA, et al
    Omission of heart transplant recipients from the 2017 Appropriate Use Criteria for Coronary Revascularization in patients with stable ischemic heart disease.
    Catheter Cardiovasc Interv. 2017 Oct 31. doi: 10.1002/ccd.27369.
    PubMed     Text format    
    
    
    
66. ARORA S, Vaidya SR, Strassle PD, Misenheimer JA, et al
    Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27357.
    PubMed     Text format     Abstract available
    
    
    
67. TUMMALA R, Banerjee K, Sankaramangalam K, Mick S, et al
    Clinical and procedural outcomes with the SAPIEN 3 versus the SAPIEN XT prosthetic valves in transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27398.
    PubMed     Text format     Abstract available
    
    
    
68. DE PALMA R, Ruck A, Settergren M, Saleh N, et al
    Percutaneous axillary arteriotomy closure during transcatheter aortic valve replacement using the MANTA device.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27383.
    PubMed     Text format     Abstract available
    
    
    
69. SHOEIB O, Burzotta F, Aurigemma C, Paraggio L, et al
    Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage: angiographic evidence and predictors for a new side effect.
    Catheter Cardiovasc Interv. 2017 Oct 25. doi: 10.1002/ccd.27248.
    PubMed     Text format     Abstract available
    
    
    
70. LEE MS, Gordin JS, Stone GW, Sharma SK, et al
    Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification.
    Catheter Cardiovasc Interv. 2017 Oct 17. doi: 10.1002/ccd.27339.
    PubMed     Text format     Abstract available
    
    
    
71. O'NEILL J, Hogarth AJ, Pearson I, Law H, et al
    Transcoronary pacing to assess myocardial viability prior to percutaneous coronary intervention: Pilot study to assess feasibility.
    Catheter Cardiovasc Interv. 2017 Oct 16. doi: 10.1002/ccd.27349.
    PubMed     Text format     Abstract available
    
    
    
72. LANDES U, Bental T, Levi A, Assali A, et al
    Temporal trends in percutaneous coronary interventions thru the drug eluting stent era: Insights from 18,641 procedures performed over 12-year period.
    Catheter Cardiovasc Interv. 2017 Oct 13. doi: 10.1002/ccd.27375.
    PubMed     Text format     Abstract available
    
    
    
73. DRAFTS BC, Choi CH, Sangal K, Cammarata MW, et al
    Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27377.
    PubMed     Text format     Abstract available
    
    
    
74. LIANG M, Yang S, Fu N, Lu C, et al
    Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Catheter Cardiovasc Interv. 2017 Oct 10. doi: 10.1002/ccd.27353.
    PubMed     Text format     Abstract available
    
    
    
75. ANDO T, Akintoye E, Telila T, Briasouolis A, et al
    Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States.
    Catheter Cardiovasc Interv. 2017 Oct 9. doi: 10.1002/ccd.27362.
    PubMed     Text format     Abstract available
    
    
    
76. HTUN WW, Grines C, Schreiber T
    Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27346.
    PubMed     Text format     Abstract available
    
    
    
77. CARRERAS ET, Kaneko T, Ramirez-Del Val F, Pelletier MP, et al
    Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27347.
    PubMed     Text format     Abstract available
    
    
    
78. EFFRON MB, Wang TY, Fonarow GC, Henry TD, et al
    The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
    Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27145.
    PubMed     Text format     Abstract available
    
    
    
79. ENEZATE T, Omran J, Al-Dadah AS, Alpert M, et al
    Fractional flow reserve versus angiography guided percutaneous coronary intervention: An updated systematic review.
    Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27302.
    PubMed     Text format     Abstract available
    
    
    September 2017
80. LIANG FW, Lee JC, Lu TH, Yin WH, et al
    Trends in proportions of hospitals and operators not meeting minimum percutaneous coronary intervention volume standards in Taiwan, 2001-2013.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27343.
    PubMed     Text format     Abstract available
    
    
    
81. REDDY G, Wang Z, Nishimura RA, Greason KL, et al
    Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27340.
    PubMed     Text format     Abstract available
    
    
    
82. IQBAL MB, Smith RD, Lane R, Patel N, et al
    The prognostic significance of incomplete revascularization and untreated coronary anatomy following percutaneous coronary intervention: An analysis of 6,755 patients with multivessel disease.
    Catheter Cardiovasc Interv. 2017 Sep 30. doi: 10.1002/ccd.27331.
    PubMed     Text format     Abstract available
    
    
    
83. AZZALINI L, Candilio L, Carlino M, Colombo A, et al
    Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017 Sep 25. doi: 10.1002/ccd.27324.
    PubMed     Text format     Abstract available
    
    
    
84. ALQAHTANI F, Aljohani S, Almustafa A, Alhijji M, et al
    Comparative outcomes of transcatheter aortic valve replacement in African American and Caucasian patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2017 Sep 23. doi: 10.1002/ccd.27257.
    PubMed     Text format     Abstract available
    
    
    
85. DREXEL T, Helmer G, Garcia S, Raveendran G, et al
    Management of left main coronary artery obstruction after transcatheter aortic valve replacement utilizing a periscope approach.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27317.
    PubMed     Text format     Abstract available
    
    
    
86. AIT ICHOU J, Larivee N, Eisenberg MJ, Suissa K, et al
    The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27316.
    PubMed     Text format     Abstract available
    
    
    
87. LEISTNER DM, Riedel M, Steinbeck L, Stahli BE, et al
    Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention-impact on physician decision-making: The OPTICO-integration study.
    Catheter Cardiovasc Interv. 2017 Sep 20. doi: 10.1002/ccd.27313.
    PubMed     Text format     Abstract available
    
    
    
88. BOEHNEL C, Rickli H, Graf L, Maeder MT, et al
    Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27255.
    PubMed     Text format     Abstract available
    
    
    
89. VAN GILS L, Kroon H, Daemen J, Ren C, et al
    Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27323.
    PubMed     Text format     Abstract available
    
    
    
90. SONG Y, Gao Z, Tang X, Ma Y, et al
    Usefulness of the SYNTAX score II to validate 2-year outcomes in patients with complex coronary artery disease undergoing percutaneous coronary intervention: A large single-center study.
    Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27321.
    PubMed     Text format     Abstract available
    
    
    June 2017
91. CARR SM, Lubbe DF, Huber PR
    Percutaneous transcatheter balloon dilatation and stenting to the inflow cannula stenosis of a left ventricular assist device.
    Catheter Cardiovasc Interv. 2017;89:1219-1223.
    PubMed     Text format     Abstract available
    
    
    
92. CARRERAS ET, Barghash M, Givertz MM, Bhatt DL, et al
    A heart within a heart.
    Catheter Cardiovasc Interv. 2017;89:1239-1241.
    PubMed     Text format     Abstract available
    
    
    
93. LUONG C, Starovoytov A, Heydari M, Sedlak T, et al
    Clinical presentation of patients with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2017;89:1149-1154.
    PubMed     Text format     Abstract available
    
    
    
94. KUO JA, Feezel AA, Putnam TN, Schutte DA, et al
    Melody valve implantation within freestyle stentless porcine aortic heterograft.
    Catheter Cardiovasc Interv. 2017;89:1224-1230.
    PubMed     Text format     Abstract available
    
    
    
95. LUNI FK, Riaz H, Khan AR, Riaz T, et al
    Clinical outcomes associated with per-operative discontinuation of aspirin in patients with coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2017;89:1168-1175.
    PubMed     Text format     Abstract available
    
    
    
96. YAHAGI K, Ladich E, Kutys R, Mori H, et al
    Pathology of balloon-expandable transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27160.
    PubMed     Text format     Abstract available
    
    
    
97. EL-SAID HG, Pockett CR, Moore JW
    Percutaneous obliteration of left ventricular cavity to eliminate aortic regurgitation and presumed coronary steal in an infant with hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2017 Jun 1. doi: 10.1002/ccd.27138.
    PubMed     Text format     Abstract available
    
    
    May 2017
98. SARNO G, Lagerqvist B, Olivecrona G, Varenhorst C, et al
    Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Catheter Cardiovasc Interv. 2017 May 22. doi: 10.1002/ccd.27030.
    PubMed     Text format     Abstract available
    
    
    
99. CONDADO JF, Corrigan FE 3rd, Lerakis S, Parastatidis I, et al
    Anatomical risk models for paravalvular leak and landing zone complications for balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.26987.
    PubMed     Text format     Abstract available
    
    
    
100. BRUNNER NW, Yue SF, Stub D, Ye J, et al
     The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
     Catheter Cardiovasc Interv. 2017 May 4. doi: 10.1002/ccd.27107.
     PubMed     Text format     Abstract available
     
     
     
101. OKOH AK, Chauhan D, Kang N, Haik N, et al
     The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.
     Catheter Cardiovasc Interv. 2017 May 2. doi: 10.1002/ccd.27083.
     PubMed     Text format     Abstract available
     
     
     
102. MORIYAMA N, Tanaka Y, Saito S
     Bailout polytetrafluoroethylene-covered stent implantation for left main bifurcation perforation using the kissing stent technique.
     Catheter Cardiovasc Interv. 2017;89:1022-1027.
     PubMed     Text format     Abstract available
     
     
     
103. BOURAS G, Jhamnani S, Ng VG, Haimi I, et al
     Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials.
     Catheter Cardiovasc Interv. 2017;89:984-991.
     PubMed     Text format     Abstract available
     
     
     April 2017
104. AUFFRET V, Regueiro A, Campelo-Parada F, Del Trigo M, et al
     Feasibility, safety, and efficacy of transcatheter aortic valve replacement without balloon predilation: A systematic review and meta-analysis.
     Catheter Cardiovasc Interv. 2017 Apr 12. doi: 10.1002/ccd.27040.
     PubMed     Text format     Abstract available
     
     
     
105. SARDAR P, Kundu A, Chatterjee S, Feldman DN, et al
     Transcatheter versus surgical aortic valve replacement in intermediate-risk patients: Evidence from a meta-analysis.
     Catheter Cardiovasc Interv. 2017 Apr 11. doi: 10.1002/ccd.27041.
     PubMed     Text format     Abstract available
     
     
     March 2017
106. YOUNG MN, Elmariah S, Kennedy KF, Inglessis I, et al
     Utilization and outcomes of transcatheter aortic valve replacement in the United States shortly after device approval.
     Catheter Cardiovasc Interv. 2017 Mar 22. doi: 10.1002/ccd.27018.
     PubMed     Text format     Abstract available
     
     
     
107. MEDURI C, Kauten J, Vannan M, Rajagopal V, et al
     First report of a simultaneous transcatheter mitral valve-in-valve and aortic valve replacement in a left ventricular assist device patient.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26983.
     PubMed     Text format     Abstract available
     
     
     
108. KOIFMAN E, Patel N, Weissman G, Kiramijyan S, et al
     Outcome of implantation of a second self-expanding valve for the treatment of residual significant aortic regurgitation.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26960.
     PubMed     Text format     Abstract available
     
     
     
109. MOHAMMAD NIJRES B, Kenny D, Kazmouz S, Hijazi ZM, et al
     Transcatheter closure of unroofed coronary sinus using covered stents in an adult with drainage of the coronary sinus to the right ventricle after supra-annular tricuspid valve replacement.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26996.
     PubMed     Text format     Abstract available
     
     
     
110. DEUSCHL F, Schofer N, Seiffert M, Hakmi S, et al
     Direct percutaneous transaxillary implantation of a novel self-expandable transcatheter heart valve for aortic stenosis.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26986.
     PubMed     Text format     Abstract available
     
     
     
111. ARAI T, Lefevre T, Hovasse T, Garot P, et al
     Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.
     Catheter Cardiovasc Interv. 2017 Mar 15. doi: 10.1002/ccd.26982.
     PubMed     Text format     Abstract available
     
     
     
112. VEJPONGSA P, Bhise V, Charitakis K, Vernon Anderson H, et al
     Early readmissions after transcatheter and surgical aortic valve replacement.
     Catheter Cardiovasc Interv. 2017 Mar 2. doi: 10.1002/ccd.26945.
     PubMed     Text format     Abstract available
     
     
     February 2017
113. CONDADO JF, Maini A, Leshnower B, Thourani V, et al
     End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
     Catheter Cardiovasc Interv. 2017 Feb 17. doi: 10.1002/ccd.26875.
     PubMed     Text format     Abstract available
     
     
     
114. RAKITA V, Lakhter V, Patil P, O'Neill BP, et al
     Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation.
     Catheter Cardiovasc Interv. 2017 Feb 7. doi: 10.1002/ccd.26931.
     PubMed     Text format     Abstract available
     
     
     
115. CZARNECKI A, Qiu F, Koh M, Prasad TJ, et al
     Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.
     Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26906.
     PubMed     Text format     Abstract available
     
     
     
116. MONTONE RA, Testa L, Fraccaro C, Montorfano M, et al
     Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
     Catheter Cardiovasc Interv. 2017 Feb 1. doi: 10.1002/ccd.26914.
     PubMed     Text format     Abstract available
     
     
     January 2017
117. HORN P, Hellhammer K, Minier M, Stenzel MA, et al
     Deep sedation Vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip(R) system.
     Catheter Cardiovasc Interv. 2017 Jan 23. doi: 10.1002/ccd.26884.
     PubMed     Text format     Abstract available
     
     
     
118. ABDELGHANI M, Tateishi H, Miyazaki Y, Cavalcante R, et al
     Angiographic assessment of aortic regurgitation by video-densitometry in the setting of TAVI: Echocardiographic and clinical correlates.
     Catheter Cardiovasc Interv. 2017 Jan 21. doi: 10.1002/ccd.26926.
     PubMed     Text format     Abstract available
     
     
     December 2016
119. JATENE T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, et al
     Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
     Catheter Cardiovasc Interv. 2016 Dec 28. doi: 10.1002/ccd.26837.
     PubMed     Text format     Abstract available
     
     
     November 2016
120. FETTERLY K, Greason K, Mathew V
     Balloon Valvuloplasty to Predict X-ray Projection Angles that are Perpendicular to Cardiovascular Structures: A TAVI Patient Feasibility Study.
     Catheter Cardiovasc Interv. 2016 Nov 29. doi: 10.1002/ccd.26879.
     PubMed     Text format     Abstract available
     
     
     
121. ZAMAN S, McCormick L, Gooley R, Rashid H, et al
     Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus transcatheter aortic valve.
     Catheter Cardiovasc Interv. 2016 Nov 12. doi: 10.1002/ccd.26857.
     PubMed     Text format     Abstract available
     
     
     
122. CONROTTO F, D'Ascenzo F, D'Amico M, Moretti C, et al
     Outcomes of patients with low-pressure aortic gradient undergoing transcatheter aortic valve implantation: A Meta-analysis.
     Catheter Cardiovasc Interv. 2016 Nov 10. doi: 10.1002/ccd.26839.
     PubMed     Text format     Abstract available
     
     
     October 2016
123. KODAMA A, Yamamoto M, Shimura T, Kagase A, et al
     Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
     Catheter Cardiovasc Interv. 2016 Oct 27. doi: 10.1002/ccd.26686.
     PubMed     Text format     Abstract available
     
     
     
124. LOYALKA P, Nascimbene A, Schechter M, Petrovic M, et al
     Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve.
     Catheter Cardiovasc Interv. 2016 Oct 3. doi: 10.1002/ccd.26723.
     PubMed     Text format     Abstract available
     
     
     September 2016
125. ACHARJI S, Agnihotri A, Carrozza J
     Transcatheter aortic valve replacement in unicuspid aortic valve stenosis (CCI-16-0461).
     Catheter Cardiovasc Interv. 2016 Sep 23. doi: 10.1002/ccd.26798.
     PubMed     Text format     Abstract available
     
     
     August 2016
126. HUDED CP, Huded JM, Sweis RN, Ricciardi MJ, et al
     The impact of delirium on healthcare utilization and survival after transcatheter aortic valve replacement.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26776.
     PubMed     Text format     Abstract available
     
     
     
127. PYXARAS SA, Toth GG, Di Gioia G, Ughi GJ, et al
     Anatomical and functional assessment of Tryton bifurcation stent before and after final kissing balloon dilatation: Evaluations by three-dimensional coronary angiography, optical coherence tomography imaging and fractional flow reserve.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26777.
     PubMed     Text format     Abstract available
     
     
     
128. ROGGEN M, Dubois C, Gewillig M
     Coronary artery stenting in a patient with progeria.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26730.
     PubMed     Text format     Abstract available
     
     
     
129. AIRHART S, Medvedev I, Dean LS
     Relative prosthesis-patient mismatch after transcatheter aortic valve replacement: The impact of morbid obesity.
     Catheter Cardiovasc Interv. 2016 Aug 27. doi: 10.1002/ccd.26721.
     PubMed     Text format     Abstract available
     
     
     
130. NAKAMURA K, Passeri JJ, Inglessis-Azuaje I
     Percutaneous closure of acute aorto-right ventricular fistula following transcatheter bicuspid aortic valve replacement.
     Catheter Cardiovasc Interv. 2016 Aug 22. doi: 10.1002/ccd.26705.
     PubMed     Text format     Abstract available
     
     
     
131. DANEK BA, Karatasakis A, Alame AJ, Nguyen-Trong PJ, et al
     Saphenous vein graft near-infrared spectroscopy imaging insights from the lipid core plaque association with clinical events near-infrared spectroscopy (ORACLE-NIRS) registry.
     Catheter Cardiovasc Interv. 2016 Aug 18. doi: 10.1002/ccd.26696.
     PubMed     Text format     Abstract available
     
     
     
132. FERRERA C, Nombela-Franco L, Garcia E, Jimenez-Quevedo P, et al
     Clinical and hemodynamic results after direct transcatheter aortic valve replacement versus pre-implantation balloon aortic valvuloplasty: A case-matched analysis.
     Catheter Cardiovasc Interv. 2016 Aug 12. doi: 10.1002/ccd.26671.
     PubMed     Text format     Abstract available
     
     
     July 2016
133. MANOLY I, Hasan R, Brazier A, Farooq V, et al
     Feasibility of hybrid off pump artery bypass grafting and transaortic transcatheter aortic valve implantation: A case series.
     Catheter Cardiovasc Interv. 2016 Jul 12. doi: 10.1002/ccd.26610.
     PubMed     Text format     Abstract available
     
     
     
134. STANGER DE, Abdulla AH, Wong FT, Alipour S, et al
     Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis.
     Catheter Cardiovasc Interv. 2016 Jul 9. doi: 10.1002/ccd.26650.
     PubMed     Text format     Abstract available
     
     
     June 2016
135. TRAYNOR MM, Greason KL, Nkomo VT, Pochettino A, et al
     Assisted care as a baseline patient risk characteristic affecting the outcome of transcatheter aortic valve insertion.
     Catheter Cardiovasc Interv. 2016 Jun 8. doi: 10.1002/ccd.26580.
     PubMed     Text format     Abstract available
     
     
     March 2016
136. CHAN AW, Wong D, Charania J
     Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis Using Lotus Valve System.
     Catheter Cardiovasc Interv. 2016 Mar 31. doi: 10.1002/ccd.26506.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: